CMMBVSDNA• 12 Months (Normalized)
CMMB vs DNA (Chemomab Therapeutics Ltd. vs Ginkgo Bioworks Holdings Inc.)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
-36.5%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
DNA Performance $10.46
+%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
-36.5 pts
DNA outperforming by 36.50 percentage points
CMMBDNA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB DNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | CMMB Price | CMMB Gain (%) | DNA Price | DNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | -36.50% | $- | - | |
| Sep 28, 2026 | $1.64 | -37.64% | $10.46 | -28.26% | -9.38% |
| Sep 25, 2026 | $2.16 | -17.87% | $10.66 | -26.89% | +9.02% |
| Sep 24, 2026 | $2.20 | -16.35% | $10.25 | -29.70% | +13.35% |
| Sep 23, 2026 | $2.28 | -13.31% | $8.58 | -41.15% | +27.84% |
| Sep 22, 2026 | $2.51 | -4.56% | $9.37 | -35.73% | +31.17% |
| Sep 21, 2026 | $2.48 | -5.70% | $7.98 | -45.27% | +39.57% |
| Sep 18, 2026 | $2.61 | -0.76% | $7.88 | -45.95% | +45.19% |
| Sep 17, 2026 | $2.80 | +6.46% | $7.84 | -46.23% | +52.69% |
| Sep 16, 2026 | $2.65 | +0.76% | $7.06 | -51.58% | +52.34% |
| Sep 15, 2026 | $2.47 | -6.08% | $6.99 | -52.06% | +45.98% |
| Sep 14, 2026 | $2.45 | -6.84% | $7.01 | -51.92% | +45.08% |
| Sep 11, 2026 | $2.58 | -1.90% | $6.75 | -53.70% | +51.80% |
| Sep 10, 2026 | $2.60 | -1.14% | $6.78 | -53.50% | +52.36% |
| Sep 09, 2026 | $2.69 | +2.28% | $6.79 | -53.43% | +55.71% |
Page 1 of 17